No CrossRef data available.
Article contents
Use of split-course hypofractionated radiotherapy in palliative treatment of head and neck cancers: how does our regimen compare with others?
Published online by Cambridge University Press: 09 March 2023
Abstract
Introduction:
Head and neck cancers (HNCs) are some of the commonest cases requiring palliative radiotherapy (PRT) in an Indian radiotherapy practice. A variety of PRT protocols have been explored with varying success.
Methods:
The study objective was to evaluate the efficacy and tolerability of a short-course hypofractionated PRT schedule in HNC patients in terms of symptom relief, tumour response, acute side effects and survival and to compare results with other PRT regimens. All patients received 30 Gy in 10 fractions over 2 weeks followed by another 20 Gy in 5 fractions after a 4 weeks gap.
Results:
Seventy-five percent of patients completed both phases of treatment. Symptom relief was seen in 71% (pain) to 76% (dysphagia) of patients. Tumour response was recorded in 73% of patients. At 12 months, the mean overall survival was 10·29 months for patients who responded to PRT compared to 7·87 months for those who did not. Results were comparable to other regimens reported in the literature, but no radiobiological advantage of a higher dose was discernible.
Conclusions:
Short-course hypofractionated PRT is effective in reducing tumour burden and relieving symptoms in HNC patients and possibly in lengthening survival. Selection of any schedule should be decided by treating oncologists based on clinical, logistic and socio-economic factors.
- Type
- Original Article
- Information
- Copyright
- © The Author(s), 2023. Published by Cambridge University Press
References
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C, Abate, D et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 2019; 5 (12): 1749. doi: 10.1001/jamaoncol.2019.2996
Google ScholarPubMed
Sharma, JD, Baishya, N, Kataki, AC, Kalita, CR, Das, AK, Rahman, T. Head and neck squamous cell carcinoma in young adults: a hospital-based study. Indian J Med Paediatr Oncol 2019; 40 (S 01): S18–S22. doi: 10.4103/ijmpo.ijmpo_252_17
Google Scholar
Aupérin, A. Epidemiology of head and neck cancers: an update. Curr Opin Oncol 2020; 32 (3): 178–186. doi: 10.1097/CCO.0000000000000629. PMID: 32209823.CrossRefGoogle ScholarPubMed
Bhattacharjee, A, Bahar, I, Saikia, A. Nutritional assessment of patients with head and neck cancer in North-East India and dietary intervention. Indian J Palliat Care 2015; 21 (3): 289. doi: 10.4103/0973-1075.164889
CrossRefGoogle ScholarPubMed
Mudur, G. India has some of the highest cancer rates in the world. BMJ 2005; 330 (7485): 215.4. doi: 10.1136/bmj.330.7485.215-c
CrossRefGoogle ScholarPubMed
Mathur, P, Sathishkumar, K, Chaturvedi, M et al. ICMR-NCDIR-NCRP Investigator Group. Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. JCO Glob Oncol 2020; 6:1063–1075. doi: 10.1200/GO.20.00122.CrossRefGoogle Scholar
Velarasan, Sk, Ramasundaram, D. Palliative hypofractionated radiation therapy in incurable head-and-neck cancer patients – 2-year follow-up experience from a tertiary center from South India. J Radiat Cancer Res 2022; 13 (2): 60. doi: 10.4103/jrcr.jrcr_53_21
CrossRefGoogle Scholar
Grewal, AS, Jones, J, Lin, A. Palliative radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 2019; 105 (2): 254–266. doi: 10.1016/j.ijrobp.2019.05.024.CrossRefGoogle ScholarPubMed
Agarwal, JP, Nemade, B, Murthy, V, et al. Hypofractionated, palliative radiotherapy for advanced head and neck cancer. Radiother Oncol 2008; 89 (1): 51–56. doi: 10.1016/j.radonc.2008.06.007
CrossRefGoogle ScholarPubMed
Chen, AM, Vaughan, A, Narayan, S, Vijayakumar, S. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme. Head Neck 2008; 30 (12): 1586–1591. doi: 10.1002/hed.20894
CrossRefGoogle ScholarPubMed
Corry, J, Peters, LJ, Costa, ID et al. The ‘QUAD SHOT’–a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiother Oncol 2005; 77 (2): 137–142. doi: 10.1016/j.radonc.2005.10.008.CrossRefGoogle Scholar
Cox, JD, Stetz, J, Pajak, TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31:1341–1346. doi: 10.1016/0360-3016(95)00060-C.CrossRefGoogle ScholarPubMed
Lutz, ST, Chow, EL, Hartsell, WF, Konski, AA. A review of hypofractionated palliative radiotherapy. Cancer 2007; 109 (8): 1462–1470. doi: 10.1002/cncr.22555
CrossRefGoogle ScholarPubMed
Miller, AB, Hoogstraten, B, Staquet, M, Winkler, A. Reporting results of cancer treatment. Cancer 1981; 47 (1): 207–214. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
Weissberg, JB, Pillsbury, H, Sasaki, CT, Son, YH, Fischer, JJ. High fractional dose irradiation of advanced head and neck cancer: implications for combined radiotherapy and surgery. Arch Otolaryngol 1983; 109 (2): 98–102. doi: 10.1001/archotol.1983.00800160032008
CrossRefGoogle ScholarPubMed
Mohanti, BK, Umapathy, H, Bahadur, S, Thakar, A, Pathy, S. Short course palliative radiotherapy of 20Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol 2004; 71 (3): 275–280. doi: 10.1016/j.radonc.2004.03.009
CrossRefGoogle Scholar
Kancherla, KN, Oksuz, DC, Prestwich, RJ et al. The role of split-course hypofractionated palliative radiotherapy in head and neck cancer. Clin Oncol (R Coll Radiol) 2011; 23 (2): 141–148. doi: 10.1016/j.clon.2010.09.006
CrossRefGoogle ScholarPubMed
Porceddu, SV, Rosser, B, Burmeister, BH et al. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment–"Hypo Trial”. Radiother Oncol 2007; 85 (3): 456–462. doi: 10.1016/j.radonc.2007.10.020.CrossRefGoogle ScholarPubMed
Al-mamgani, A, Tans, L, Van rooij, PH, Noever, I, Baatenburg de jong, RJ, Levendag, PC. Hypofractionated radiotherapy denoted as the “Christie scheme”: an effective means of palliating patients with head and neck cancers not suitable for curative treatment. Acta Oncol 2009; 48 (4): 562–570. doi: 10.1080/02841860902740899.CrossRefGoogle Scholar
Lok, BH, Jiang, G, Gutiontov, S et al. Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers. Oral Oncol 2015; 51 (10): 957–962. doi: 10.1016/j.oraloncology.2015.07.011.CrossRefGoogle ScholarPubMed
Murthy, V, Kumar, D, Budrukkar, A, Gupta, T, Ghosh-Laskar, S, Agarwal, J. Twice-weekly palliative radiotherapy for locally very advanced head and neck cancers. Indian J Cancer 2016; 53 (1): 138. doi: 10.4103/0019-509X.180847
CrossRefGoogle ScholarPubMed
Nguyen, NT, Doerwald-Munoz, L, Zhang, H et al. 0-7-21 hypofractionated palliative radiotherapy: an effective treatment for advanced head and neck cancers. Br J Radiol 2015; 88 (1049): 20140646. doi: 10.1259/bjr.20140646.CrossRefGoogle ScholarPubMed
Bledsoe, TJ, Noble, AR, Reddy, CA et al. Split-course accelerated hypofractionated radiotherapy (SCAHRT): a safe and effective option for head and neck cancer in the elderly or infirm. Anticancer Res 2016; 36 (3): 933–939.Google ScholarPubMed
Finnegan, TS, Bhatt, NH, Shaughnessy, JN et al. Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: institutional experience and review of palliative regimens. J Community Support Oncol 2016; 14 (1): 29–36. doi: 10.12788/jcso.0201.CrossRefGoogle ScholarPubMed
Ghoshal, S, Chakraborty, S, Moudgil, N, Kaur, M, Patel, FD. Quad shot: a short but effective schedule for palliative radiation for head and neck carcinoma. Indian J Palliat Care 2009; 15 (2): 137–140. doi: 10.4103/0973-1075.58460. PMID: 20668593; PMCID: PMC2902115.CrossRefGoogle Scholar
Paliwal, R, Kumar-Patidar, A, Walke, R, Hirapara, P, Jain, S, Raj-Bardia, M. Palliative hypo-fractionated radiotherapy in locally advanced head and neck cancer with fixed neck nodes. Iran J Cancer Prev 2012; 5 (4): 178–182.Google ScholarPubMed
Shishodia, NP, Divakar, DD, Al Kheraif, AA et al. End stage palliative care of head and neck cancer: a case study. Asian Pac J Cancer Prev 2015; 16 (3): 1255–1258. doi: 10.7314/apjcp.2015.16.3.1255.CrossRefGoogle ScholarPubMed
Monnier, L, Touboul, E, Durdux, C, Lang, P, St Guily, JL, Huguet, F. Hypofractionated palliative radiotherapy for advanced head and neck cancer: the IHF2SQ regimen. Head Neck 2013; 35 (12): 1683–1688. doi: 10.1002/hed.23219.CrossRefGoogle ScholarPubMed
Stevens, CM, Huang, SH, Fung, S et al. Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma. Int J Radiat Oncol Biol Phys 2011; 81 (4): 958–963. doi: 10.1016/j.ijrobp.2010.06.055.CrossRefGoogle ScholarPubMed
Minatel, E, Gigante, M, Franchin, G et al. Combined radiotherapy and bleomycin in patients with inoperable head and neck cancer with unfavourable prognostic factors and severe symptoms. Oral Oncol 1998; 34 (2): 119–122. doi: 10.1016/s1368-8375(97)00073-0.CrossRefGoogle ScholarPubMed
Benhmida, S, Sun, R, Gherga, E et al. Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases. Cancer Radiother 2020; 24 (8): 812–819. doi: 10.1016/j.canrad.2020.03.013.CrossRefGoogle ScholarPubMed